EpCAM is known to be overexpressed in epithelial cancers associated with enhanced proliferation, invasion, metastasis, malignant potential, chemo-/radioresistance, and decreased overall survival of cancer patients [1–4]. The gene discussed is EPCAM; the disease is cancer.